The world's leading manufacturer of affinity ligands now makes best-in-class affinity purification resins for IgGs, Fc fragments, COVID-19 vaccines (SARS-COV-2) and Adeno-associated viral vectors.
Traditional custom affinity resin development methods start with one scaffold, explore limited ligand sequence space and struggle to deliver consistent results, ultimately requiring multiple iterations that extend the overall timeline. By starting with more than 50 multifarious scaffolds, Repligen generates unprecedented library diversity to achieve high binding capacity, selectable pH requirements and caustic stability on the first iteration at an unparalleled success rate.
AAV affinity resins provide one-step purification of adeno-associated virus (AAV) 2,8 and 9 vectors with potential alkaline clean-in-place regeneration for improved process economics. A 50 µm cross-linked agarose matrix bead ensures compatibility with standard bioprocess columns and flowrates (3 bar at 300 cm/hour).
NGL COVID-19 Spike Protein affinity resin
NGL COVID-19 Spike Protein Affinity Resin binds the SARS-CoV-2 Spike Protein receptor binding domain (RBD) to yield exceptional purity in a single chromatography step. The resin is available in off-the shelf, pre-packed and pre-qualified OPUS® Columns for rapid implementation as well as in loose resin formats.
CaptivA® Protein Aアフィニティ樹脂
Protein A樹脂のお値打ちな選択肢。
CaptivA® Protein Aアフィニティ樹脂は、従来の樹脂の数分の1のコストで、優れた結合容量、苛性安定性、低浸出を実現します。
固定化Protein A（IPA）アフィニティ樹脂
Repligenの固定化Protein A（IPA）樹脂は、良好な特性を持ち、長年業界に受け入れられてきました。